Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dust mite SLIT for pediatric allergic rhinitis
ChiCTR2500105309Phase 4Not yet recruiting
- Sponsor
- Chengdu Women's and Children's Central Hospital
- Start
- Jul 2025
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of House dust mite allergen extract in allergic rhinitis (AR) (2 arms), sponsored by Chengdu Women's and Children's Central Hospital. Primary endpoints: Total nasal symptoms score (TNSS), Total medication score (TMS) and 2 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
House dust mite allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2500105309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105309.